openPR Logo
Press release

Excruciating Technological Advancements To Drive The Minimal Residual Disease Market

05-11-2022 08:16 AM CET | Health & Medicine

Press release from: Persistence Market Research

Excruciating Technological Advancements To Drive The Minimal

The global Minimal Residual Disease Market is expected to stimulate at a good rate In Upcoming Years. Virtual consultations are amongst the ongoing trends. They mitigate the spreading of contagious ailments, thereby facilitating better efficiency. The gap regarding the demand-supply ratio could also be bridged this way. With this practice being followed, the developing economies would benefit better, as the cost to commute could be curtailed.

The minimal residual diseases are leukemic cells that stay in a patient during or after treatment. The ongoing treatment of cancer through chemotherapy or radiotherapy is not every time capable of eliminating all the carcinogenic cells and it may moreover be a cause of malignancy.

Minimal residual disease test is useful to confirm the traces of leukemic cells during and after the treatment of cancer. The different treatments employed throughout the onset can be tested by minimal residual disease confirmatory test to check the efficacy of the different tests and choose the best treatment to eradicate the cancer cells. The recurrence of cancer and cell proliferation can be quantitatively measured by the minimal residual disease test.

Get Free Sample Copy of this Report@

US FDA approved first Next-Generation Sequencing based test; clonoSEQ Assay that uses multiplex polymerase chain reaction and NGS to identify and quantify certain gene sequences extracted from bone marrow of patients suffering from acute lymphoblastic leukemia and myeloma.

The rising number of patients with cancer is expected to be the prime factor for the growth of minimal residual disease market. The awareness among people to confirm the presence of carcinogens is expected to be the one of the surging drivers for the minimal residual disease market.

The patients with ongoing cancer treatment is anticipated to be the most important factor that will grow the minimal residual disease market. The inability of flow cytometry, FISH and polymerase chain reactions to quantify beyond 1 per 100,000 cells is certainly expected to shift the focus of patients towards minimal residual disease market with novel technologies that detect approximately 10 times more for recurrence.

The organ transplants wherein major histocompatibility test is required can be one of the applications where minimal residual disease tests employed for more specificity. The highly funded oncology testing market is expected to rise the number of technologies and the specificity of each test which will help grow the minimal residual disease market.

Request of Table of Content@

Minimal Residual Disease Market: Segmentation

Based on test technique


Based on detection target

Solid Tumors

Based on test type

DNA-based test
RNA-based test
Immunological test

Based on end user

Laboratory centers
Specialty Clinics

The minimal residual disease market is broadly classified into FISH, PCR and NGS depending on the test carried out for the detection of the minimal residual disease. Based on the test type the minimal residual disease market is segmented into DNA based test, RNA based test and immunological test.

Access Full Report@

The segmentation of minimal residual disease market based on the detection target is solid tumors, lymphoma, leukemia and others. The end users of the minimal residual disease market can be hospitals, laboratory centers and specialty clinics.

North America is one of the most prevalent regions in the world for minimal residual disease market, followed by Europe. However, rise in medical tourism in regions such as Brazil, Thailand, Malaysia and Singapore also offer lucrative opportunity for the growth of the minimal residual disease market.

Rising number of hospitals in developing regions such as Asia pacific is expected to offer significant growth opportunity for the minimal residual disease market.

Complete Report Details@

Some of the key players operating in the global minimal residual disease market are Adaptive Biotechnologies, Proteus Digital Health, Juno Therapeutics, Navidea Biopharmaceuticals, Kite Pharma, iRepertoire, Inc, Macrogen Corp, Natera, Inc., Macrogen Corp and others.

Related Reports:

Molecular Grade Plates Market -

Humanized Liver Mice Model Market -

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales -
Website -

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Excruciating Technological Advancements To Drive The Minimal Residual Disease Market here

News-ID: 2621302 • Views: 463

More Releases from Persistence Market Research

Precision in Motion: The Visionary Advancements of the Optical Encoders Market in 2033
Precision in Motion: The Visionary Advancements of the Optical Encoders Market i …
The Optical Encoders Market is set to reach approximately US$ 2.5 billion in 2023 and is anticipated to surge at a CAGR of 9.2% from 2023 to 2033 according to a Persistence Market Research (PMR) report. By the end of 2033, optical encoder is estimated to reach a valuation of US$ 5.9 billion. During the historical period 2018 to 2022, the global market expanded at 12.0% CAGR. Click Here to Get Free
Nourishing Health and Beauty: The Growth Potential of the Beta-Carotene Market in 2033
Nourishing Health and Beauty: The Growth Potential of the Beta-Carotene Market i …
The global beta-carotene market is forecasted to expand at a CAGR of 5.9% and increase from a value of US$ 372.3 million in 2023 to US$ 657.5 million by the end of 2033. Worldwide consumption of beta-carotene is estimated at 3,045 tons in 2023. This is forecasted to rise at a CAGR of 5.2% to reach 5,060 tons by the end of 2033, as per the latest market report by Persistence
Connecting the World at Speed: The Evolution of the Microwave Transmission Equipment Market in 2033
Connecting the World at Speed: The Evolution of the Microwave Transmission Equip …
The Global Microwave Transmission Equipment Market revenue was estimated at US$ 5.3 billion in 2021. It is anticipated to expand at a CAGR of 4.7% during 2022 and 2032, as per a Persistence Market Research (PMR) report. In 2032, microwave transmission equipment revenue is expected to reach a valuation of US$ 8.7 billion. Cellular communication segment is likely to hold a leading share in the global market. It is expected
Unleashing Imagination: Navigating the Dynamic Landscape of the Mixed Reality Market in 2033
Unleashing Imagination: Navigating the Dynamic Landscape of the Mixed Reality Ma …
As per Persistence Market Research, global Mixed Reality Market sales totaled US$1.2 billion in 2022.Over the next ten years (2022 to 2032), global demand for mixed reality is projected to increase at 35.6% CAGR. Total market valuation at the end of 2032 is expected to reach US$ 24.6 billion. Demand in the market is likely to remain high for wireless devices, making it a key revenue-generating segment for companies. This is

All 5 Releases

More Releases for Minimal

Minimal Window System Market Size Estimation: 2022, Development Trends , Growth …
The "Minimal Window System Market" Report 2022 provides a comprehensive analysis of the current market size, observable trends, key regions, growth rate, and projections. The study offers a thorough analysis of the key persuading factors, market figures in terms of revenues, segmental data, regional data, and country-wise data. The report provides a detailed assessment of the key market dynamics and a qualitative analysis of the structure of the Minimal Window
EvolIft - Lift Off for minimal friction
In order to achieve the European Union's climate protection targets, CO2 emissions at fleet level must be reduced to < 60g CO2/km by 2030. The contribution of the sealing industry is, to reduce power losses to a technically possible minimum. KACO has further developed a principle based on turbine technology to enable its application in the automotive sector as well as in other industrial areas. The dynamic seal with the
Minimal Invasive Surgeries & Technological Advancement Underpin Endoscopic Clips …
The surge in the cases of bleeding in the course of surgeries has upped the endoscopic clips market. Further, conducive government initiatives, enhanced health care infrastructure, swelling demand for endoscopic treatment, embracement of minimal invasive surgeries and upsurge in cases of cancer have propped up the market. These assimilations are according to the report titled, “Endoscopic Clips Market—Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026,” which has been
Gynecology Surgical Instruments Market - Minimal Competition Over 2025
Gynecology Surgical Instruments Market: Snapshot Change in the preference of patients regarding minimally invasive surgery as opposed to open surgical surgeries has fueled the adoption of robotic assisted procedures. Faster recovery time, decreased hospital stay, and decreased postoperative pain are some of the benefits of minimally invasive surgeries. Robotic technologies are being used to perform complicated gynecological surgeries and offering a better view of the area to be operated and allow
Beta Exchange Minimal Functionality
Beta Exchange is the early version of Exscudo exchange, real-time trading tool operating 24 hours a day, 365 days a year. As announced earlier, open beta testing of Exscudo exchange will start in February, and trading on the actual exchange - in Q1 2018. Open testing is an important stage of the Exscudo exchange development. During this period Exscudo team will fix all the major bugs, and users will have a
Climatic monitoring ensures optimal farm management with minimal manpower
Wireless data logger solutions with free of charge cloud services support smart farming economically and effectively T&D Corporation’s RTR 500 series provides a wireless data logging system that makes cultivation easier and helps to optimize harvesting in agricultural businesses. The cloud-connected data loggers are available with sensors for several different parameters, such as temperature, humidity, illuminance, UV, voltage, 4-20mA, pulse and CO2. They can be flexibly combined to fit individual needs